Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta‐analysis

Read full text Summarise with VIRAT
Authors: Hager Awad ElGeed, Ahmed Tehemar, Mohamed Gasimelseed, Ahmed Mohammad Gharaibeh, Muhammad Abdul Hadi, Kazeem Babatunde Yusuff, Amani Zidan, Ahmed Awaisu
Cited by: 0
References: 68

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883). Eight electronic databases were searched from inception to 31 December 2025. Quantitative studies assessing renal dose adjustment practices in adults with advanced CKD were included in the review. Two reviewers independently performed study selection, data extraction and quality assessment. Random‐effects meta‐analyses (REML) were used to pool adherence proportions at prescription/order and patient levels. Results Thirty studies were included in the review. The observational studies were of moderate to high quality, while the two interventional studies had moderate risk of bias due to confounding. Prescribing adherence to renal dosing guidelines ranged from 33% to 87.7%. Pooled prescription/order‐level guideline adherence ( n = 16) was 0.48 (95% CI 0.42–0.55; I 2 ≈ 98%). Conversely, the pooled patient‐level guideline adherence ( n = 7) was higher at 0.7 (95% CI 0.57–0.83; I 2 ≈ 99.9%). The study results suggest that the prevalence of prescribing non‐adherence to renal dosing guidelines was high and may be associated with various adverse drug events. Conclusions The available evidence suggests that adherence to renal dosing recommendations in adults with advanced CKD is variable and may be suboptimal. The pooled estimate suggests a potential safety gap, although substantial heterogeneity limits interpretation. Furthermore, non‐adherence to renal dosing recommendations was associated with adverse clinical consequences and increased healthcare utilization. High‐quality studies are needed to inform effective strategies aimed at improving prescribing practices and medication safety.

Fields of Study & Subjects

Pharmaceutical Practices and Patient Outcomes Medication Adherence and Compliance Pharmacy and Medical Practices

Publication details

Journal / source
British Journal of Clinical Pharmacology
Pages
e70731–e70731
Publication date
12 August 2026
Language
EN